| Patient | Geronimo |
|---|---|
| Date of birth | 1829-06-01 |
| Identifiers | MRN HR-NI016-SYN-TD; SSN (made up) 000-16-4729 |
| Document date | 2026-11-01 |
| Author | Roberta Whitehorse-Lindgren, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing care at the clinic for poor sleep, nightmares and drinking at night: a trauma-informed history with the interpreter, PTSD, alcohol, depression and cognitive screening, liver tests, a recent fall, and his safety. Concerns: He wants to sleep through the night without the old battles and the dead coming back to him; He does not want whisky to rule his nights, and he does not want to fall again; He wants care that respects who he is, his people and his own ways of healing. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1906-07-08 | active | S |
| Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicines | One tablet daily | Oral route | 1906-07-22 | active | S |
| Sertraline 25 mg oral tablet, one tablet each morning, raised to 50 mg after the sodium check | One tablet each morning | Oral route | 1906-08-19 to 1906-09-23 | completed | S |
| Sertraline 50 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1906-09-23 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for fever or aches, no more than 2,000 mg a day while his liver recovers | One or two tablets every 6 hours as needed, no more than 2,000 mg a day | Oral route | 1906-09-02 to 1906-09-16 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Advance care planning conversation, about 20 minutes, with the interpreter | 1906-10-07 to 1906-10-07 | completed | S |
| Chest X-ray, two views: lungs clear, no consolidation or effusion; heart size normal; healed rib deformity on the left | 1906-09-02 to 1906-09-02 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1906-10-07 | Influenza vaccine, high-dose, for the coming season (preferred at 65 and older) | completed | S |
| 1906-10-07 | Pneumococcal conjugate vaccine (PCV20), one dose; no earlier pneumococcal vaccine | completed | S |
| 1906-10-07 | RSV vaccine, one dose, recommended for all adults 75 and older | completed | S |
| 1906-10-28 | Tdap vaccine; no booster he can recall | completed | S |
| 1906-10-28 | Recombinant zoster vaccine, first of two doses | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1850s to 1880s | Eight wounds in wars with Mexican forces, including gunshot wounds of the right thigh (bullet retained), left forearm, left side and back, a saber wound below the right knee, and a glancing shot below the left eye | D (CLM-0006) |
| 1850s to 1880s | Blow to the top of the head with a musket butt, with loss of consciousness; no lasting effect recorded | D (CLM-0006) |
| 1851 (1858 in his own account) | Killing of his mother, wife and three children by Mexican troops, and his grief afterwards in his own words | D (CLM-0004, CLM-0005) |
| 1886 onward | Prisoner of war since 1886: hard labor at Fort Pickens apart from his family, then Alabama, where many of his people died of disease, and Fort Sill | D (CLM-0007, CLM-0008) |
| before 1906 | Twice jailed in the guardhouse for drinking whisky as a prisoner of war, by his own account | D (CLM-0012) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Killed by Mexican troops in an attack on the camp; not a medical cause of death | D (CLM-0004) | |
| child | Three young children killed in the same attack | D (CLM-0004) |
| Concern | Status | Evidence |
|---|---|---|
| He wants to sleep through the night without the old battles and the dead coming back to him | active | S |
| He does not want whisky to rule his nights, and he does not want to fall again | active | S |
| He wants care that respects who he is, his people and his own ways of healing | active | S |
Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.1 on 1906-07-08; Hemoglobin [Mass/volume] in Blood 13.9 on 1906-07-08; MCV [Entitic mean volume] in Red Blood Cells by Automated count 101 on 1906-07-08; Platelets [#/volume] in Blood by Automated count 182 on 1906-07-08; Sodium [Moles/volume] in Serum or Plasma 137 on 1906-09-23; Potassium [Moles/volume] in Serum or Plasma 4.2 on 1906-07-08; Creatinine [Mass/volume] in Serum or Plasma 1 on 1906-07-08; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1901)/1.73 sq M 78 on 1906-07-08; Glucose [Mass/volume] in Serum or Plasma 94 on 1906-07-08; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29 on 1906-10-28; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 25 on 1906-10-28; Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 48 on 1906-10-28; Albumin [Mass/volume] in Serum or Plasma 3.8 on 1906-07-08; Bilirubin.total [Mass/volume] in Serum or Plasma 0.9 on 1906-07-08; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 388 on 1906-07-08; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 1906-07-08; Phosphatidylethanol [Mass/volume] in Blood 14 on 1906-10-28; PC-PTSD-5 score [PC-PTSD-5] 5 on 1906-07-08; PTSD PCL-5 score [PCL-5] 24 on 1906-10-28; Total score [AUDIT] 5 on 1906-10-28; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 1906-10-07; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 1906-10-28; Total score [Mini-Cog] 5 on 1906-10-07 [S]
Strengths and supports: Strengths and supports: his standing among his people, his faith, his work with horses and cattle, his skill in telling his own story, a long record of endurance, and clear views about what he wants [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Poor sleep for many years with nightmares and unwanted memories of past violence, worse over the past year; drinks at night to sleep; cause to be assessed | resolved | confirmed | G47.00 | S — Synthetic presenting problem anchored to the documented killing of his family and his years of war; resolved into the diagnosis of post-traumatic stress disorder at the consultation. Not a claim about his real sleep. |
| Post-traumatic stress disorder, chronic, confirmed with the CAPS-5 interview (PCL-5 56 at intake); prolonged grief disorder considered and criteria not met | active | confirmed | F43.12 | S — Synthetic modern diagnosis made at the consultation by current criteria; not a retrospective diagnosis of the historical person. |
| Alcohol use disorder, moderate (four DSM-5-TR criteria): drinking at night to sleep, more than intended, unable to cut down, and a fall walking home after drinking; AUDIT 19; liver tests show the pattern of heavy drinking | active | confirmed | F10.20 | S — Synthetic modern diagnosis anchored to his own statement that he was twice jailed for drinking whisky as a prisoner of war; not a claim about his real drinking. |
| A fall in the past month while walking home at night after drinking: bruised left hip, no fracture on examination; Timed Up and Go 13 seconds | active | confirmed | Z91.81 | S — Synthetic fall-risk finding; it is not his documented last fall, which is history after the episode. |
| Acute bronchitis with cough and low fever for six days, chest X-ray clear, oxygen saturation 95%; treated without antibiotics; resolved | resolved | confirmed | J20.9 | S — Synthetic self-limited illness; not a historical claim and not his documented last illness. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1906-07-08 | Leukocytes [#/volume] in Blood by Automated count | 6.1 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1906-07-08 | Hemoglobin [Mass/volume] in Blood | 13.9 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 1906-07-08 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 101 | fL | 80-100 fL | High | S |
| 1906-07-08 | Platelets [#/volume] in Blood by Automated count | 182 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1906-07-08 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1906-07-08 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1906-07-08 | Creatinine [Mass/volume] in Serum or Plasma | 1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1906-07-08 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1901)/1.73 sq M | 78 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1906-07-08 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1906-07-08 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 58 | U/L | 10-40 U/L | High | S |
| 1906-07-08 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 36 | U/L | 7-56 U/L | Normal | S |
| 1906-07-08 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 112 | U/L | 8-61 U/L | High | S |
| 1906-07-08 | Albumin [Mass/volume] in Serum or Plasma | 3.8 | g/dL | 3.5-5 g/dL | Normal | S |
| 1906-07-08 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.9 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
| 1906-07-08 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 388 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1906-07-08 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1906-07-08 | Phosphatidylethanol [Mass/volume] in Blood | 236 | ng/mL | <=20 ng/mL | High | S |
| 1906-07-08 | PC-PTSD-5 score [PC-PTSD-5] | 5 | {score} | S | ||
| 1906-07-08 | PTSD PCL-5 score [PCL-5] | 56 | {score} | S | ||
| 1906-07-08 | Total score [AUDIT] | 19 | {score} | S | ||
| 1906-07-08 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 3 | {score} | S | ||
| 1906-07-08 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 11 | {score} | S | ||
| 1906-07-08 | Total score [Mini-Cog] | 4 | {score} | S | ||
| 1906-07-22 | PTSD PCL-5 score [PCL-5] | 54 | {score} | S | ||
| 1906-08-19 | PTSD PCL-5 score [PCL-5] | 46 | {score} | S | ||
| 1906-08-19 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 10 | {score} | S | ||
| 1906-08-19 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 10-40 U/L | High | S |
| 1906-08-19 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 | U/L | 7-56 U/L | Normal | S |
| 1906-08-19 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 84 | U/L | 8-61 U/L | High | S |
| 1906-09-23 | PTSD PCL-5 score [PCL-5] | 35 | {score} | S | ||
| 1906-09-23 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 1906-09-23 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1906-09-23 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 33 | U/L | 10-40 U/L | Normal | S |
| 1906-09-23 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 27 | U/L | 7-56 U/L | Normal | S |
| 1906-09-23 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 63 | U/L | 8-61 U/L | High | S |
| 1906-09-23 | Phosphatidylethanol [Mass/volume] in Blood | 41 | ng/mL | <=20 ng/mL | High | S |
| 1906-10-28 | PTSD PCL-5 score [PCL-5] | 24 | {score} | S | ||
| 1906-10-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1906-10-28 | Total score [AUDIT] | 5 | {score} | S | ||
| 1906-10-28 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 29 | U/L | 10-40 U/L | Normal | S |
| 1906-10-28 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 25 | U/L | 7-56 U/L | Normal | S |
| 1906-10-28 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 48 | U/L | 8-61 U/L | Normal | S |
| 1906-10-28 | Phosphatidylethanol [Mass/volume] in Blood | 14 | ng/mL | <=20 ng/mL | Normal | S |
| 1906-10-07 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 1906-10-07 | Total score [Mini-Cog] | 5 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1906-07-08 | Body height | 173 | cm | S |
| 1906-07-08 | Body weight | 66 | kg | S |
| 1906-07-08 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 1906-07-08 | Systolic blood pressure | 136 | mm[Hg] | S |
| 1906-07-08 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1906-07-08 | Heart rate | 84 | /min | S |
| 1906-07-08 | Respiratory rate | 16 | /min | S |
| 1906-07-08 | Body temperature | 36.6 | Cel | S |
| 1906-07-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1906-07-22 | Body height | 173 | cm | S |
| 1906-07-22 | Body weight | 66.2 | kg | S |
| 1906-07-22 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 1906-07-22 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1906-07-22 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1906-07-22 | Heart rate | 78 | /min | S |
| 1906-07-22 | Respiratory rate | 16 | /min | S |
| 1906-07-22 | Body temperature | 36.5 | Cel | S |
| 1906-07-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1906-08-19 | Body height | 173 | cm | S |
| 1906-08-19 | Body weight | 66.8 | kg | S |
| 1906-08-19 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 1906-08-19 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1906-08-19 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1906-08-19 | Heart rate | 74 | /min | S |
| 1906-08-19 | Respiratory rate | 16 | /min | S |
| 1906-08-19 | Body temperature | 36.6 | Cel | S |
| 1906-08-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1906-09-23 | Body height | 173 | cm | S |
| 1906-09-23 | Body weight | 67.2 | kg | S |
| 1906-09-23 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1906-09-23 | Systolic blood pressure | 130 | mm[Hg] | S |
| 1906-09-23 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1906-09-23 | Heart rate | 72 | /min | S |
| 1906-09-23 | Respiratory rate | 16 | /min | S |
| 1906-09-23 | Body temperature | 36.6 | Cel | S |
| 1906-09-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1906-10-28 | Body height | 173 | cm | S |
| 1906-10-28 | Body weight | 67.6 | kg | S |
| 1906-10-28 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 1906-10-28 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1906-10-28 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1906-10-28 | Heart rate | 70 | /min | S |
| 1906-10-28 | Respiratory rate | 16 | /min | S |
| 1906-10-28 | Body temperature | 36.5 | Cel | S |
| 1906-10-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1906-10-07 | Body height | 173 | cm | S |
| 1906-10-07 | Body weight | 67.4 | kg | S |
| 1906-10-07 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1906-10-07 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1906-10-07 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1906-10-07 | Heart rate | 70 | /min | S |
| 1906-10-07 | Respiratory rate | 16 | /min | S |
| 1906-10-07 | Body temperature | 36.6 | Cel | S |
| 1906-10-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1906-09-02 | Body height | 173 | cm | S |
| 1906-09-02 | Body weight | 66.6 | kg | S |
| 1906-09-02 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 1906-09-02 | Systolic blood pressure | 134 | mm[Hg] | S |
| 1906-09-02 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1906-09-02 | Heart rate | 92 | /min | S |
| 1906-09-02 | Respiratory rate | 18 | /min | S |
| 1906-09-02 | Body temperature | 37.9 | Cel | S |
| 1906-09-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1906-07-08 | Establishing care at the clinic for poor sleep, nightmares and drinking at night: a trauma-informed history with the interpreter, PTSD, alcohol, depression and cognitive screening, liver tests, a recent fall, and his safety | finished | S |
| 1906-07-22 | Two-week review, seen the same day by psychiatry: the CAPS-5 interview, the diagnosis, grief, treatment for alcohol use, and the choice of therapy | finished | S |
| 1906-08-19 | Six-week review: cognitive processing therapy, naltrexone, sleep, mood and medicine | finished | S |
| 1906-09-23 | Eleven-week review: therapy progress, sertraline and sodium, drinking and falls | finished | S |
| 1906-10-28 | Sixteen-week review after twelve therapy sessions: symptoms, drinking, safety and his plan | finished | S |
| 1906-10-07 | Initial annual wellness visit | finished | S |
| 1906-09-02 | Same-day sick visit for cough and fever | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Trauma-informed, culturally safe care: ask how he wishes to be addressed and what matters to him, the Apache interpreter at every visit, time and plain explanations, consent before each question about the past and each examination, no demand to retell the killings or name the dead, and his history shared only as he chooses | completed | GL-SAMHSA-TIP57-2014, GL-IHS-TRAD | S |
| Psychiatry consultation at the clinic's visiting session to confirm the diagnosis with a structured interview, weigh grief against prolonged grief disorder, and advise on therapy and medicines | completed | GL-PTSD-2023, GL-APA-PTSD-2017 | S |
| PTSD screening and tracking: PC-PTSD-5 and PCL-5 at intake, a CAPS-5 interview to confirm, and the PCL-5 at each visit | completed | GL-PTSD-2023 | S |
| Cognitive processing therapy, twelve weekly sessions with the clinic's behavioral health therapist and the interpreter, without the written trauma account, with worksheets done aloud, shorter sessions when he tires, and video sessions on weeks he cannot come | completed | GL-PTSD-2023, GL-APA-PTSD-2017 | S |
| Medicine for PTSD only if he wants it: sertraline starting at 25 mg with a sodium check within the first month, then 50 mg; no benzodiazepines; prazosin not started now because of his age and recent fall, and reconsidered with standing blood pressure checks if nightmares persist | completed | GL-PTSD-2023, GL-BEERS-2023 | S |
| Alcohol: brief counseling with his own goals, DSM-5-TR criteria, PEth explained as part of care, thiamine, and liver and kidney tests before medicine; no withdrawal medicine needed (no past withdrawal seizures or delirium) | completed | GL-APA-AUD-2018, GL-NIAAA-CORE, GL-USPSTF-ALC-2018 | S |
| Naltrexone 50 mg daily with liver tests at four to six weeks and at four months, a wallet card about opioid pain medicines, and acamprosate (dose set by kidney function) if naltrexone cannot be used | completed | GL-APA-AUD-2018, GL-NIAAA-CORE | S |
| Safety: a structured safety assessment at intake, a written safety plan in his own words, the 988 Suicide & Crisis Lifeline, small medicine supplies, and safety review at every visit | completed | GL-SUICIDE-2024, GL-USPSTF-DEP-2023 | S |
| Falls: Timed Up and Go at visits, orthostatic blood pressure, no drinking before riding or walking out at night, a light on the path to his house, and an exercise program for strength and balance | completed | GL-USPSTF-FALLS-2024 | S |
| Traditional healing offered alongside clinic care at his choice, through the clinic's traditional medicine program, with nothing asked about his beliefs | completed | GL-IHS-TRAD | S |
| Vaccines due at his age: pneumococcal conjugate, high-dose influenza, RSV, recombinant zoster and Tdap, at the wellness visit and the following visit | completed | GL-CDC-IMZ-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Sleep most nights with nightmares no more than once a week | 1906-10-28 | completed | Nightmares from most nights to about once every two weeks; sleeping six hours most nights | S |
| Lower PTSD symptoms by a meaningful amount (PCL-5 down at least 10 to 20 points) | 1906-10-28 | completed | PCL-5 56 to 24 after twelve sessions of cognitive processing therapy | S |
| Drink no more than one drink on any day, and no drinking before riding | 1906-10-28 | completed | AUDIT 19 to 5; PEth 236 to 14 ng/mL; one evening of heavy drinking in sixteen weeks | S |
| No further falls | 1906-10-28 | completed | No falls in sixteen weeks; Timed Up and Go 13 to 11 seconds | S |
Structured synthetic safety assessment on 1906-07-08: current ideation absent, intent absent, plan absent. Outpatient care with close follow-up. Risk factors reviewed without detail: post-traumatic stress, moderate alcohol use disorder, depressive symptoms, older age, living alone, a recent fall and many losses. He has no firearm; medicines are dispensed in small amounts. A written safety plan was made with him in his own words through the interpreter, and the 988 Suicide & Crisis Lifeline (call or text 988, with interpreter services) and the clinic's number were written on a card he carries. Safety is reviewed at every visit [S]